norfloxacin has been researched along with Hypoxia in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balazuc, AM | 1 |
| Lagranderie, M | 1 |
| Chavarot, P | 1 |
| Pescher, P | 1 |
| Roseeuw, E | 1 |
| Schacht, E | 1 |
| Domurado, D | 1 |
| Marchal, G | 1 |
1 other study available for norfloxacin and Hypoxia
| Article | Year |
|---|---|
In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver.
Topics: Animals; Antitubercular Agents; Drug Design; Drug Resistance, Bacterial; Female; Hypoxia; Isoniazid; | 2005 |